ArticleBMC cancer2022

Prognostic model for overall survival that includes the combination of platelet count and neutrophil-lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma.

Miki Takenaka Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.